A rapid and efficient method for expansion of human mesenchymal stem cells. 2007

Sanne K Both, and Adrie J C van der Muijsenberg, and Clemens A van Blitterswijk, and Jan de Boer, and Joost D de Bruijn
Institute for Biomedical Technology, University of Twente, Bilthoven, the Netherlands.

During the past decade, there has been much interest in the use of human mesenchymal stem cells (hMSCs) in bone tissue engineering. HMSCs can be obtained relatively easily and expanded rapidly in culture, but for clinical purposes large numbers are often needed and the cost should be kept to a minimum. A rapid and efficient culturing protocol would therefore be beneficial. In this study, we examined the effect of different medium compositions on the expansion and osteogenic differentiation of bone marrow-derived hMSCs from 19 donors. We also investigated the effect of low seeding density and dexamethasone on both hMSCs expansion and their in vitro and in vivo osteogenic differentiation capacity. HMSCs seeded at a density of 100 cells/cm2 had a significantly higher growth rate than at 5000 cell/cm2, which was further improved by the addition of dexamethasone. Expanded hMSCs were characterized in vitro on the basis of positive staining for CD29, CD44, CD105, and CD166. The in vitro osteogenic potential of expanded hMSCs was assessed by flow cytometric staining for alkaline phosphatase. In vivo bone-forming potential of the hMSCs was assessed by seeding the cells in ceramic scaffolds, followed by subcutaneous implantation in nude mice and histopathologic assessment of de novo bone formation after 6-week implantation. Expanded hMSCs from all donors displayed similar osteogenic potential independent of the culture conditions. On the basis of these results we have developed an efficient method to culture hMSCs by seeding the cells at 100 cells/cm2 in an alpha-minimal essential medium-based medium containing dexamethasone.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Sanne K Both, and Adrie J C van der Muijsenberg, and Clemens A van Blitterswijk, and Jan de Boer, and Joost D de Bruijn
April 2013, BioResearch open access,
Sanne K Both, and Adrie J C van der Muijsenberg, and Clemens A van Blitterswijk, and Jan de Boer, and Joost D de Bruijn
February 2009, Journal of biotechnology,
Sanne K Both, and Adrie J C van der Muijsenberg, and Clemens A van Blitterswijk, and Jan de Boer, and Joost D de Bruijn
July 2016, Cell transplantation,
Sanne K Both, and Adrie J C van der Muijsenberg, and Clemens A van Blitterswijk, and Jan de Boer, and Joost D de Bruijn
January 2016, Cell transplantation,
Sanne K Both, and Adrie J C van der Muijsenberg, and Clemens A van Blitterswijk, and Jan de Boer, and Joost D de Bruijn
October 2013, Organogenesis,
Sanne K Both, and Adrie J C van der Muijsenberg, and Clemens A van Blitterswijk, and Jan de Boer, and Joost D de Bruijn
May 2012, Journal of tissue engineering and regenerative medicine,
Sanne K Both, and Adrie J C van der Muijsenberg, and Clemens A van Blitterswijk, and Jan de Boer, and Joost D de Bruijn
February 2019, Journal of cellular biochemistry,
Sanne K Both, and Adrie J C van der Muijsenberg, and Clemens A van Blitterswijk, and Jan de Boer, and Joost D de Bruijn
December 2019, Journal of visualized experiments : JoVE,
Sanne K Both, and Adrie J C van der Muijsenberg, and Clemens A van Blitterswijk, and Jan de Boer, and Joost D de Bruijn
January 2020, Stem cells international,
Sanne K Both, and Adrie J C van der Muijsenberg, and Clemens A van Blitterswijk, and Jan de Boer, and Joost D de Bruijn
November 2011, Biotechnology letters,
Copied contents to your clipboard!